Schematic illustration of the DM-based antibody nanoformulations for the penetration of the ocular barrier and the treatment of CorNV (IMAGE)

Tsinghua University Press

Schematic illustration of the DM-based antibody nanoformulations for the penetration of the ocular barrier and the treatment of CorNV

Caption

This study screened an anti-VEGF single-domain antibody (sdVE01) and designed four disulfide molecules (DM) to construct the disulfide-based antibody eyedrops, which may be an attractive non-invasive strategy for treating ocular neovascularization disease.

Credit

Nano research, Tsinghua University Press

Usage Restrictions

News organizations may use or redistribute this image, with proper attribution, as part of news coverage of this paper only.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.